Department of Clinical Sciences and Community Health.
Department of Biomedical and Clinical Sciences L. Sacco, Università degli Studi di Milano, Milan, Italy.
Eur J Cancer Prev. 2021 Nov 1;30(6):472-479. doi: 10.1097/CEJ.0000000000000651.
Recent trends in male breast cancer have been inadequately studied. We updated mortality trends in selected countries and regions worldwide using most recent available data and we predicted figures for 2020.
We extracted official death certification data for male breast cancer and population estimates from the WHO and the Pan American Health Organization databases, from 2000 to 2017. We computed age-standardized (world population) death rates for selected countries and regions worldwide. We used joinpoint regression analysis to identify significant changes in trends and to predict death numbers and rates for 2020.
In 2015-2017, Central-Eastern Europe had a rate of 2.85/1 000 000, and Russia of 2.22, ranking among the highest. North-Western and Southern Europe, the European Union as a whole and the USA showed rates ranging between 1.5 and 2.0. Lower rates were observed in most Latin American countries, with values below 1.35/1 000 000, in Australia, 1.22, and Japan, 0.58. Between 2000-2004 and 2015-2017, age-adjusted death rates decreased between 10 and 40% in North-Western Europe, Russia, and the USA, and between 1.5 and 25% in the other areas under study, except Latin America (+0.8%). Except for Central-Eastern Europe, predicted rates for 2020 were favourable.
Advancements in management are likely the main drivers of the favourable trends in male breast cancer death rates over the last decades. Delayed diagnosis and limited access to effective care explain the higher mortality in some areas.
男性乳腺癌的近期趋势研究不足。我们利用最新的可用数据更新了全球部分国家和地区的死亡率趋势,并预测了 2020 年的数据。
我们从世界卫生组织和泛美卫生组织数据库中提取了 2000 年至 2017 年男性乳腺癌的官方死亡证明数据和人口估计数据。我们计算了全球部分国家和地区的年龄标准化(世界人口)死亡率。我们使用 joinpoint 回归分析确定了趋势的显著变化,并预测了 2020 年的死亡人数和死亡率。
2015-2017 年,中东欧的死亡率为 2.85/100 万,俄罗斯为 2.22,位居前列。西北欧和南欧、整个欧盟和美国的死亡率在 1.5 至 2.0 之间。大多数拉丁美洲国家的死亡率较低,低于 1.35/100 万,澳大利亚为 1.22,日本为 0.58。在 2000-2004 年至 2015-2017 年期间,西北欧、俄罗斯和美国的年龄标准化死亡率下降了 10%至 40%,而在其他研究地区,除拉丁美洲(+0.8%)外,死亡率下降了 1.5%至 25%。除中东欧外,2020 年的预测死亡率较为乐观。
管理水平的提高可能是男性乳腺癌死亡率在过去几十年中呈下降趋势的主要原因。诊断延迟和有效治疗机会有限解释了一些地区死亡率较高的原因。